share_log

Leap Therapeutics Provides Update on BeiGene Option Agreement For DKN-01; Says BeiGene's Option Under Exclusive Option And License Agreement Has Expired

Benzinga ·  Mar 16, 2023 16:16
Leap Therapeutics Provides Update on BeiGene Option Agreement For DKN-01; Says BeiGene's Option Under Exclusive Option And License Agreement Has Expired
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment